Posaconazole cerebrospinal concentrations in an HIV-infected patient with brain mucormycosis.
A
A
Calcagno
L
L
Baietto
F G
FG
De Rosa
M C
MC
Tettoni
V
V
Libanore
R
R
Bertucci
A
A
D'Avolio
G
G
Di Perri
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D000354:Africa, Western; D000935:Antifungal Agents / Q000008:administration & dosage / Q000493:pharmacokinetics*; D001921:Brain / Q000000981:diagnostic imaging / Q000382:microbiology / Q000473:pathology; D018791:CD4 Lymphocyte Count; D020314:Central Nervous System Fungal Infections / Q000188:drug therapy*; D002555:Cerebrospinal Fluid / Q000737:chemistry*; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D020128:Inhibitory Concentration 50; D008279:Magnetic Resonance Imaging; D009091:Mucormycosis / Q000188:drug therapy*; D011859:Radiography; D014230:Triazoles / Q000008:administration & dosage / Q000493:pharmacokinetics*
D000935:Antifungal Agents; D014230:Triazoles; C101425:posaconazole